Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf)

**Product type:** Human Prescription Drug

**Active ingredient:** HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB

**Strength:** 20000; 600; 600 U/10mL; mg/10mL; mg/10mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761170)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC], HER2/neu Receptor Antagonist [EPC]